- APHEXDA is the first innovation in stem cell mobilization for multiple myeloma to be approved in the U.S. in a decade - - One dosage of APHEXDA plus filgrastim enabled a majority of patients to ...

The UK's first stem cell collection centre strictly dedicated to transplants has started welcoming donors. The Anthony Nolan Cell Collection Centre, based at Nottingham's Queen's Medical Centre (QMC), ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved motixafortide combined with filgrastim for mobilization of hematopoietic stem cells into ...

The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Stem cell transplantation is an important treatment method for ...

All cell types found in the body are derived from stem cells. However, genetic mutations can impact the ability of stem cells to develop into fully functional cells. Also, as the body ages, the number ...

South Texas is entering a new era in health care. South Texas Blood & Tissue has launched what it calls the world’s only mobile cell therapy collection vehicle, recording its first donation just two ...

The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma. The FDA approved motixafortide ...

The Anthony Nolan Cell Collection Centre has welcomed the first people to donate their stem cells for lifesaving transplants and medical research. Creating 1,300 new donation slots a year, the centre ...

Dose-intensive cyclophosphamide, etoposide, cisplatin reinduction for relapsed/refractory aggressive non-Hodgkin lymphoma (r/r-aNHL). The comparison of up-front autologous peripheral stem cell ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...